Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Kyowa Kirin to Draw Up 5-Year Midterm Plan Focusing on Development of Global Products: President Hanai
August 4, 2015
-
ORGANIZATION “All-Japan” System Needed to Contend with Top Global Drug Makers: JPMA R&D Head
August 3, 2015
-
BUSINESS Wholesalers Must Ponder Use of Reps for New Business: Mediceo CEO
July 31, 2015
-
BUSINESS AbbVie Pres. Says Japan Attracting Foreign Investments, Confident in Hep C Drug
July 31, 2015
-
BUSINESS ASCO Immunotherapy Roundup - 4: Merck KGaA Trailing Rivals with ADCC-Inducing Avelumab
July 30, 2015
-
BUSINESS Delving into Securities Filings - 2: Drug Maker Employees Decrease 0.9% in 5 Years
July 30, 2015
-
BUSINESS New AbbVie Japan Chief Says Generics Making Room for Innovation
July 29, 2015
-
BUSINESS Delving into Securities Filings - 1: Average Salary of 25 Makers Up 4.9% in 5 Years, Generic Players Close in on Top-Tier Firms
July 29, 2015
-
ORGANIZATION Drug Pricing Tomorrow: JPA’s Abe Eyes Longer-Term Trial for Key Pricing Premium
July 28, 2015
-
BUSINESS Japan Drug Makers Should Consider Mergers, Other Deals to Survive: Chugai Chief
July 27, 2015
-
BUSINESS Toho to Differentiate Itself through Customer Support Rather than Prices: Pres.
July 24, 2015
-
ORGANIZATION Drug Pricing Tomorrow: Full Interview with Kenporen Vice President Shirakawa
July 24, 2015
-
REGULATORY Drug Pricing Organization Proposes Re-Pricing of Products with Huge Sales
July 23, 2015
-
REGULATORY Z2 Rule, DPC Incentive Need Revisions in Line with New Generic Target: MOF Budget Examiner
July 22, 2015
-
REGULATORY PAFSC’s First Committee to Discuss Actelion’s Tracleer, Other Products on July 31
July 21, 2015
-
TRENDS IFN-Free Drugs Upending Hepatitis C Market Landscape
July 17, 2015
-
BUSINESS ASCO Immunotherapy Roundup - 3: AZ Set to Harness Rich Pipeline to Pursue Combo Strategy
July 16, 2015
-
BUSINESS As 80% Era Looms, 3 Generic Majors Will Emerge as Dominant Suppliers: Sawai
July 16, 2015
-
ORGANIZATION Drug Pricing Tomorrow: Kenporen Veep Wants Holistic Drug Policy in FY2016 Reform
July 15, 2015
-
REGULATORY Drug Pricing Tomorrow: Full Interview with MHLW Economic Affairs Head Jo - Part 2
July 15, 2015
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…